
Cessation of Hormone Replacement Therapy After Reports of Adverse Findings From Randomized Controlled Trials: Evidence From a British Birth Cohort
Author(s) -
Gita D. Mishra,
Helen S. Kok,
Russell Ecob,
Rachel Cooper,
Rebecca Hardy,
Diana Kuh
Publication year - 2006
Publication title -
american journal of public health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.284
H-Index - 264
eISSN - 1541-0048
pISSN - 0090-0036
DOI - 10.2105/ajph.2005.071332
Subject(s) - medicine , demography , hormone replacement therapy (female to male) , social class , adverse effect , cohort , publicity , obesity , randomized controlled trial , marketing , business , sociology , political science , law , testosterone (patch)
We examined the cessation of hormone replacement therapy (HRT) among British women, by educational level, social class, and cardiovascular risk factors, at the time of publicity about 2 clinical trials of HRT that were halted after adverse findings.